CD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens (Q81661836)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2005

Language	Label	Description	Also known as
English	CD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens	scientific article published on 01 May 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

CD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

immunologic adjuvant

1 reference

based on heuristic

inferred from title

author name string

Tom A Barr

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jennifer Carlring

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Andrew W Heath

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

3477-3482

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

A potent adjuvant effect of CD40 antibody attached to antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Immune regulation by CD40 and its ligand GP39.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Fortifying B cells with CD154: an engaging tale of many hues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Functions of CD40 on B cells, dendritic cells and other cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

CD40-CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

CD40 antibody as an adjuvant induces enhanced T cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Mice deficient for the CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Monoclonal antibodies to murine CD40 define two distinct functional epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

BAFF AND APRIL: a tutorial on B cell survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

BAFF: a fundamental survival factor for B cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

CD40 ligand-transduced co-stimulation of T cells in the development of helper function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

Enhanced in vivo immune responses to bacterial lipopolysaccharide by exogenous CD40 stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.12.025

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837371%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81661836&oldid=1744643315"